Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: Three-year results of an open-label extension of 2 randomized clinical trials - TAP report no. 5

Mark S. Blumenkranz, Neil M. Bressler, Susan B. Bressler, Guy Donati, Gary Edd Fish, Laurie A. Haynes, Hilel Lewis, Joan W. Miller, Jordi M. Monés, Michael J. Potter, Constantin Pournaras, Al Reaves, Philip J. Rosenfeld, Andrew P. Schachat, Ursula Schmidt-Erfurth, Michel Sickenberg, Lawrence J. Singerman, Jason S. Slakter, H. Andrew Strong, Stéphane Vannier

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: Three-year results of an open-label extension of 2 randomized clinical trials - TAP report no. 5'. Together they form a unique fingerprint.

Medicine & Life Sciences